2021 is setting up to be a VERY promising year for cannabis stocks.
President-elect Biden is good for the cannabis industry and this election was a big step forward. Biden isn’t the most cannabis-friendly Democrat, but he has expressed interest in decriminalizing and rescheduling cannabis.
Over the years, thousands of U.S. cannabis companies have struggled to access banking services, master product distribution, and navigate legal obstacles. The change in Washington’s leadership could lead to a big boost in profitability and growth, rewarding investors and bumping stock prices to jaw-dropping highs.
While the entire cannabis sector stands to benefit from the shift in power, a popular group of early industry leaders could benefit the most.
This exclusive group of stocks benefits from a number of competitive advantages over their peers.
- They are the largest companies in the U.S. cannabis industry
- The companies operate in multiple states
- They own hard-to-get permits to grow and sell cannabis
- They have the best product portfolios
- Cash in the bank to fund more growth
3 Stocks Could Lead Sector in 2021
#1 – Cresco Labs (CSE: CL, OTC: CRLBF) is an early leader in the U.S. cannabis industry. Headquartered in Chicago with a market cap of more than $1 billion, Cresco owns an impressive portfolio of cannabis assets. That includes 29 retail licenses, 18 dispensaries, and 15 production facilities. Cresco is positioned for long-term success in the cannabis industry.
Despite the promising outlook, Cresco shares are trading 50% below the 52-week high. I think this weakness is an opportunity to capitalize while most of the Street ignores this stock.
Cannabis Stock trades alerted its members of this awesome opportunity and sent out a trade signal for Cresco Labs on April 3. We closed that trade on July 7, securing a 50% gain in 12 weeks.
We’re still watching Cresco for our Cannabis Stock Trades members and will add this holding back to our model portfolio when the time is right.
#2 – Green Thumb Industries (CSE: GTI, OTC: GTBIF) is another early leader in the U.S. cannabis industry.
Headquartered in Chicago, Illinois, Green Thumb has a market cap of $2.2 billion. This powerhouse company also owns and operates an impressive portfolio of cannabis assets – it operates in 12 states, owns licenses for 96 retail locations, and operates 13 manufacturing facilities.
Last quarter, Green Thumb became the first U.S. cannabis company to report revenue of more than $100 million in one quarter. Green Thumb is also positioned for long-term success in the U.S. cannabis industry.
The impressive results have been driving a big rebound on the chart. Green Thumb has rebounded close to 300% from the 52-week low in March. Despite the big rebound, Green Thumb is trading 35% below the all-time high made in September of 2018.
#3 – Curaleaf Holdings (CSE: CURL, OTC: CURLF) is the largest cannabis company in the U.S. with a market value of $4.8 billion.
Headquartered in Wakefield, Massachusetts, Curaleaf just completed a $700 million acquisition that gives it the best cannabis portfolio in the industry. That includes operations in 23 states, 135 dispensary licenses, 88 operating dispensaries, 30 processing facilities, 22 cultivation facilitates and more than 1.6 million square feet of cultivation capacity.
It’s possible that Curaleaf will be the first U.S. cannabis company to generate more than $1 billion in annual sales. After the acquisition, no other U.S. cannabis company comes close to Curaleaf’s portfolio of dispensaries, greenhouses, and processing facilities. This portfolio of cannabis assets should drive huge revenue growth in the next few years – particularly because U.S. cannabis sales are expected to surge.
The acquisition has driven a big rebound on the chart. Shares are up almost 200% since hitting a 52-week low in March. Despite the rebound, Curaleaf still has plenty of potential for more gains.
Curaleaf is in a position to deliver strong revenue growth for the next few quarters and years, and that should drive shares higher.
The key to capitalizing on these three cannabis stocks will be properly timing your entry and then knowing when to capture projects. In life (and trading), timing is everything!
How Will You Capitalize on Cannabis in 2021?
While Cresco, Green Thumb, and Curaleaf have the markings of solid 2021 plays, nothing is certain.
Cannabis is not a “set it and forget it” sector. This lucrative industry requires constant attention, research, and analysis.
On top of that, simply parking your money in one or two cannabis stocks is a recipe for disaster. However, finding the right mix of cannabis stocks can help grow and protect your money.
Cannabis Stock Trades Will Do the Hard Work for You
Let me say it again — despite the incredible opportunity, not all cannabis stocks will do well. In fact, the cannabis industry is loaded with questionable companies that will probably fail.
Do you really have time to spend hours researching the cannabis industry, trying to separate the winning companies from ones that could implode?
Outsource the hard work to Cannabis Stock Trades.
Get the information you need to invest in the best cannabis stocks – the ones will solid footing and massive growth potential.
Start your free trial and get:
- Access to our model portfolio of vetted stocks
- See the stocks that are core portfolio holdings for the pot sector
- Trade alerts and full reports
- Daily sector updates and analysis
- Updates on regulatory events that can unleash huge rallies
- And more
Editor, Cannabis Stock Trades
Author Michael Vodicka owns shares of Cresco Labs (CRLBF), Green Thumb Industries (GTBIF), and Curaleaf Holdings (CURLF).
What CST Members are Saying…
Results are being delivered and you can see how his picks have done since inception on the website. The service has been worth every penny! – Bob P.
I am so happy that I decided to subscribe to the Cannabis Stock Trades service. It has been outstanding! I am an experienced stock trader, and I can tell you that Michael Vodicka really knows what he is doing. – Douglas W.
Thanks for the valuable insight over the last many, many months. I have made a good deal of profit following your recommendations. I am taking my profits off the table for now and waiting for a lower entry point to get back in. – Richard S.